Compare NATR & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NATR | EU |
|---|---|---|
| Founded | 1972 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 424.6M | 353.5M |
| IPO Year | 1995 | 2011 |
| Metric | NATR | EU |
|---|---|---|
| Price | $27.24 | $2.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $28.33 | $4.00 |
| AVG Volume (30 Days) | 91.4K | ★ 2.2M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.00 | 11.76 |
| EPS | ★ 1.06 | N/A |
| Revenue | ★ $480,144,000.00 | $43,155,000.00 |
| Revenue This Year | $7.76 | $212.11 |
| Revenue Next Year | $4.82 | $29.88 |
| P/E Ratio | $25.79 | ★ N/A |
| Revenue Growth | ★ 5.67 | N/A |
| 52 Week Low | $11.27 | $1.28 |
| 52 Week High | $28.14 | $4.19 |
| Indicator | NATR | EU |
|---|---|---|
| Relative Strength Index (RSI) | 64.31 | 58.18 |
| Support Level | $13.70 | $2.06 |
| Resistance Level | $28.00 | $2.17 |
| Average True Range (ATR) | 0.78 | 0.12 |
| MACD | 0.26 | 0.06 |
| Stochastic Oscillator | 92.69 | 90.62 |
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.